Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2015-11-17 Declaration of Voting R…
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Results of Annual General Meeting 1 page 236.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement titled 'RESULTS OF ANNUAL GENERAL MEETING' and details the voting results of various resolutions put to the shareholders at the AGM. It includes the number of votes for, against, abstentions, and proxies for each resolution. There is no financial data or report content, only the official voting results. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is short (2241 characters) and it is clearly a voting result announcement, not a full report or presentation.
2015-11-17 English
Smoking cessation trial results of ongoing data analysis 2 pages 241.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX media announcement from Invion Limited providing additional results from ongoing analysis of a Phase 2 clinical trial for a drug (INV102). It discusses clinical trial data, biomarker analysis, and plans for Phase 3 studies. The content is focused on clinical trial progress and scientific data rather than financial results or regulatory filings. The document is relatively short (6305 characters) and is clearly an announcement of clinical trial data rather than a financial or regulatory report. There is no indication of financial statements, audit information, management changes, or shareholder voting results. Therefore, the document best fits the category of a Regulatory Filings (RNS) as a general announcement that does not fit other specific categories such as earnings release or annual report.
2015-11-16 English
Corporate presentation November 2015 31 pages 3.4MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation November 2015' and contains detailed information about the company's clinical-stage drug development programs, trial data, milestones, and forward strategy. It includes slides with clinical trial results, pipeline updates, and scientific rationale for the drug candidates. The content is structured as a presentation aimed at investors, focusing on financial and strategic information rather than a formal regulatory filing or financial report. There is no indication that this is an official annual or quarterly report, audit report, or earnings release. The length (15,000 characters) and detailed content support that this is a full investor presentation document rather than a brief announcement or regulatory filing. Therefore, the appropriate classification is Investor Presentation (IP).
2015-11-09 English
Invion announces Share Purchase Plan 1 page 233.5KB
Capital/Financing Update Classification · 95% confidence The document is an announcement titled 'INVION ANNOUNCES SHARE PURCHASE PLAN' and describes an invitation to shareholders to participate in a share purchase plan (SPP). It details the terms of the SPP, the use of funds, and company progress but does not contain financial statements or detailed financial results. The document length is 3679 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on fundraising through a share purchase plan, which is a capital raising activity. Therefore, the document fits the category of Capital/Financing Update (CAP).
2015-11-09 English
Letter to shareholders SPP rules and sample application 10 pages 873.5KB
Capital/Financing Update Classification · 95% confidence The document is a detailed letter and offer to shareholders regarding a Share Purchase Plan (SPP) by Invion Limited. It includes terms of the offer, pricing, record and closing dates, intended use of funds, eligibility criteria, and instructions for participation. The content focuses on a capital raising activity through issuing new shares to existing shareholders at a discount. There are no financial statements or quarterly results presented, nor is this a regulatory announcement or a report publication notice. The document is clearly an update on a financing activity involving share issuance to raise capital. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence in this classification.
2015-11-09 English
Share Purchase Plan Cleansing Notice 1 page 226.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement titled 'SHARE PURCHASE PLAN – CLEANSING NOTICE'. It references ASIC Class Order 09/425 and compliance with the Corporations Act 2001, specifically regarding the offer of shares under a Share Purchase Plan (SPP) without disclosure. The document is a formal notice to the ASX about the company's intention to issue shares under the SPP and compliance with regulatory requirements. It does not contain financial statements, earnings data, or detailed report content. It is an announcement related to capital raising activities and share issuance. Therefore, the most appropriate classification is 'Capital/Financing Update' (CAP). The document length is short and it is not a report publication announcement or regulatory filing fallback. Confidence is high due to clear references to share issuance and regulatory compliance for a share purchase plan.
2015-11-09 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.